Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/NON-RI)

15th May 2014 12:15

RNS Number : 2297H
Bank of America Merrill Lynch
15 May 2014
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Merrill Lynch, Pierce, Fenner and Smith Incorporated

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

AstraZeneca PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

Pfizer Inc

(d) Date position held/dealing undertaken:

14/05/2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

YES

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

US0463531089

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

23,400

0.002

5939

0.000

(2) Derivatives (other than options):

0

0

0

(3) Options and agreements to purchase/sell:

137,200

0.011

129,300

0.010

 

TOTAL:

160,600

0.013

135,239

0.011

 

All interests and all short positions should be disclosed.

 

Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit USD

ADR US0463531089

Buy

900

78.06

ADR US0463531089

Buy

30809

78.07

ADR US0463531089

Buy

10661

78.08

ADR US0463531089

Buy

9410

78.09

ADR US0463531089

Buy

26643

78.1

ADR US0463531089

Buy

500

78.105

ADR US0463531089

Buy

27724

78.11

ADR US0463531089

Buy

200

78.115

ADR US0463531089

Buy

29806

78.12

ADR US0463531089

Buy

11358

78.13

ADR US0463531089

Buy

15864

78.14

ADR US0463531089

Buy

212

78.145

ADR US0463531089

Buy

40046

78.15

ADR US0463531089

Buy

11476

78.16

ADR US0463531089

Buy

25550

78.17

ADR US0463531089

Buy

7330

78.18

ADR US0463531089

Buy

1659

78.19

ADR US0463531089

Buy

4852

78.2

TOTAL

255000

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit USD

ADR US0463531089

Buy

149401

78.109

ADR US0463531089

Buy

82617

78.143

ADR US0463531089

Buy

22982

78.162

TOTAL

255000

 

 

(b) Derivatives transactions (other than options)

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit USD

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 (ii) Exercising

 

Class of relevant security

Product description

e.g. call option

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

Yes

 

 

Date of disclosure:

15/05/2014

Contact name:

Stacy Otieno

Telephone number:

0207 995 1335

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY ANEXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS(OR WHERE RI STATUS IS NOT APPLICABLE)Rule 8.5 of the Takeover Code (the "Code")

 

1.

KEY INFORMATION

(a)

Name of exempt principal trader:

MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED

(b)

Name of offeror/offeree in relation to whoserelevant securities this form relates:Use a separate form for each offeror/offeree

Pfizer Inc

(c)

Name of the party to the offer with which exempt principal trader is connected:

Pfizer Inc

(d)

Date position held/dealing undertaken:

14/05/2014

(e)

Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of anyother party to this offer?

No

 

2.

POSITIONS OF THE EXEMPT PRINCIPAL TRADER

(a)

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Common - US7170811035

Interests

Short Positions

Number

%

Number

%

(1)

Relevant securities ownedand/or controlled:

4,869,297

0.08%

7,006,463

0.11 %

(2)

Derivatives (other thanoptions):

0

0%

0

0%

(3)

Options and agreements topurchase/sell:

12,336,300

0.19%

16,987, 000

0.27 %

TOTAL:

17,205,597

0.27%

23,993,463

0.38%

 

All interests and all short positions should be disclosed.Details of any open derivative or option positions, or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b)

Rights to subscribe for new securities (including directors' and other executive options)

 

Class of relevant security in relation to which subscription right exists:

N/A

Details, including nature of the rights concerned and relevant percentages:

N/A

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit USD

Common - US7170811035

Purchase

42402

28.961

Common - US7170811035

Purchase

139

28.972

Common - US7170811035

Purchase

275645

28.976

Common - US7170811035

Purchase

300

28.985

Common - US7170811035

Purchase

6700

28.99

Common - US7170811035

Purchase

152428

28.998

Common - US7170811035

Purchase

130000

29

Common - US7170811035

Purchase

70972

29.1

Common - US7170811035

Purchase

287

29.160

Total

678,873

 

Class of relevant security

Purchase/sale

Number of securities

Price per unit USD

Common - US7170811035

Sale

10429

28.930

Common - US7170811035

Sale

200

28.935

Common - US7170811035

Sale

22593

28.940

Common US7170811035

Sale

200

28.945

Common US7170811035

Sale

8558

28.950

Common US7170811035

Sale

3282

28.955

Common US7170811035

Sale

39426

28.960

Common US7170811035

Sale

2099

28.965

Common US7170811035

Sale

94021

28.970

Common US7170811035

Sale

8680

28.975

Common US7170811035

Sale

206515

28.980

Common US7170811035

Sale

4800

28.982

Common US7170811035

Sale

200

28.983

Common US7170811035

Sale

25367

28.985

Common US7170811035

Sale

71197

28.990

Common US7170811035

Sale

300

28.990

Common US7170811035

Sale

1700

28.992

Common US7170811035

Sale

1900

28.993

Common US7170811035

Sale

4384

28.995

Common US7170811035

Sale

48359

29.000

Common US7170811035

Sale

100

29.002

Common US7170811035

Sale

4849

29.005

Common US7170811035

Sale

297

29.010

Common US7170811035

Sale

200

29.015

Common US7170811035

Sale

6059

29.020

Common US7170811035

Sale

1506

29.025

Common US7170811035

Sale

24493

29.030

Common US7170811035

Sale

1669

29.035

Common US7170811035

Sale

12292

29.040

Common US7170811035

Sale

1800

29.045

Common US7170811035

Sale

19

29.050

Common US7170811035

Sale

46652

29.100

Common US7170811035

Sale

287

29.160

Common US7170811035

Sale

127342

29.209

Total

781,775

 

 (b)

 

Derivatives transactions (other than options)

 

Class of relevant security

Product descriptione.g. CFD

Nature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit USD

Common US7170811035

 

Swap

 

Short

 

19

29.1036

Common US7170811035

 

Swap

 

Short

 

139

28.9747

Common US7170811035

 

Swap

 

Long

9

29.0464

Common US7170811035

 

Swap

 

Long

5

29.0464

Common US7170811035

 

Swap

 

Long

5

29.0464

Common US7170811035

 

Swap

 

Long

127342

29.20716

 

 

 

(c)

Options transactions in respect of existing securities

(i)

Writing, selling, purchasing or varying

Class ofrelevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number ofsecurities to which option relates

Exercise priceper unit

Typee.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

(ii)

Exercising

Class of relevant security

Product descriptione.g. call option

Number of securities

Exercise Price per unit

N/A

N/A

N/A

N/A

 

(d)

Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealinge.g. subscription, conversion

Details

Price per unit (if applicable)

N/A

N/A

N/A

N/A

 

The currency of all prices and other monetary amounts should be stated.Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

4.

OTHER INFORMATION

 

(a)

Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none"

None

 

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) The voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"

None

 

(c)

Attachments

 

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

Date of disclosure:

15/05/2014

Contact name:

Stacy Otieno

Telephone number:

0207 995 1335

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory InformationService and must also be emailed to the Takeover Panel at [email protected].The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FEOAAMBTMBBBBII

Related Shares:

AstrazenecaPFZ.L
FTSE 100 Latest
Value8,680.29
Change47.96